ATE205397T1 - Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen - Google Patents
Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE205397T1 ATE205397T1 AT97905395T AT97905395T ATE205397T1 AT E205397 T1 ATE205397 T1 AT E205397T1 AT 97905395 T AT97905395 T AT 97905395T AT 97905395 T AT97905395 T AT 97905395T AT E205397 T1 ATE205397 T1 AT E205397T1
- Authority
- AT
- Austria
- Prior art keywords
- natural human
- human alpha
- pharmaceutical compositions
- compositions containing
- containing natural
- Prior art date
Links
- 102000006992 Interferon-alpha Human genes 0.000 title 1
- 108010047761 Interferon-alpha Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 206010019799 Hepatitis viral Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000009826 neoplastic cell growth Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 201000001862 viral hepatitis Diseases 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96RM000136 IT1283945B1 (it) | 1996-02-28 | 1996-02-28 | Uso dell'interferone alfa naturale umano da cellule linfoblastoidi per la terapia delle epatiti virali, neoplasie e sindromi da |
| IT96RM000427 IT1284852B1 (it) | 1996-06-14 | 1996-06-14 | Uso dell'interferone alfa naturale umano da cellule leucocitarie per la terapia delle epatiti virali, neoplasie e sindromi da |
| PCT/IT1997/000040 WO1997031649A1 (en) | 1996-02-28 | 1997-02-27 | PHARMACEUTICAL COMPOSITIONS COMPRISING NATURAL HUMAN α-INTERFERON |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE205397T1 true ATE205397T1 (de) | 2001-09-15 |
Family
ID=26332096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97905395T ATE205397T1 (de) | 1996-02-28 | 1997-02-27 | Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6884411B1 (de) |
| EP (1) | EP0886527B1 (de) |
| JP (1) | JP2000506839A (de) |
| KR (1) | KR100394382B1 (de) |
| AT (1) | ATE205397T1 (de) |
| AU (1) | AU722987B2 (de) |
| BR (1) | BR9707772A (de) |
| DE (1) | DE69706657T2 (de) |
| DK (1) | DK0886527T3 (de) |
| EA (1) | EA001147B1 (de) |
| ES (1) | ES2160927T3 (de) |
| GE (1) | GEP20012489B (de) |
| PT (1) | PT886527E (de) |
| WO (1) | WO1997031649A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2129011C1 (ru) * | 1998-04-09 | 1999-04-20 | Григорян Седа Суреновна | Способ интерферониндуцирующей или интерферонактивированной терапии и средство для его осуществления |
| ATE466085T1 (de) | 2002-09-09 | 2010-05-15 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
| ITMI20030826A1 (it) * | 2003-04-18 | 2004-10-19 | Unihart Corp | Composizione farmaceutica contenente interferone per il |
| ES2303492A1 (es) * | 2004-08-18 | 2008-08-01 | Instituto Cientifico Y Tecnologico De Navarra S.A. | Uso del factor de crecimiento semejante a la insulina tipo i y de interferon alfa en el tratamiento de una enfermedad hepatica cronica, kit y composiciones que los comprenden. |
| WO2006032711A1 (es) * | 2004-08-18 | 2006-03-30 | Instituto Científico Y Tecnológico De Navarra S.A. | Uso del factor de crecimiento semejante a la insulina tipo i y de interferón alfa en el tratamiento de una enfermedad hepática crónica, kit y composiciones que los comprenden |
| US20080260820A1 (en) * | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA878295B (en) | 1986-11-06 | 1988-05-03 | Amarillo Cell Culture Co. Inc. | Treatment of immuno-resistant disease |
| CA1320905C (en) * | 1986-11-06 | 1993-08-03 | Joseph M. Cummins | Treatment of immuno-resistant disease |
| TW224053B (de) * | 1991-09-13 | 1994-05-21 | Paul B Chretien | |
| US6387365B1 (en) * | 1995-05-19 | 2002-05-14 | Schering Corporation | Combination therapy for chronic hepatitis C infection |
| US5980884A (en) * | 1996-02-05 | 1999-11-09 | Amgen, Inc. | Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon |
| HUP9602024A3 (en) * | 1996-07-25 | 1999-05-28 | Toth Sandor | Pharmaceutical composition containing aminoacid for external use |
-
1997
- 1997-02-27 PT PT97905395T patent/PT886527E/pt unknown
- 1997-02-27 AT AT97905395T patent/ATE205397T1/de not_active IP Right Cessation
- 1997-02-27 DK DK97905395T patent/DK0886527T3/da active
- 1997-02-27 EA EA199800770A patent/EA001147B1/ru not_active IP Right Cessation
- 1997-02-27 GE GEAP19974506A patent/GEP20012489B/en unknown
- 1997-02-27 KR KR10-1998-0706297A patent/KR100394382B1/ko not_active Expired - Fee Related
- 1997-02-27 AU AU22299/97A patent/AU722987B2/en not_active Ceased
- 1997-02-27 BR BR9707772-0A patent/BR9707772A/pt not_active Application Discontinuation
- 1997-02-27 US US09/125,122 patent/US6884411B1/en not_active Expired - Fee Related
- 1997-02-27 DE DE69706657T patent/DE69706657T2/de not_active Expired - Fee Related
- 1997-02-27 JP JP9530771A patent/JP2000506839A/ja not_active Ceased
- 1997-02-27 ES ES97905395T patent/ES2160927T3/es not_active Expired - Lifetime
- 1997-02-27 EP EP97905395A patent/EP0886527B1/de not_active Expired - Lifetime
- 1997-02-27 WO PCT/IT1997/000040 patent/WO1997031649A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DK0886527T3 (da) | 2002-03-04 |
| EA001147B1 (ru) | 2000-10-30 |
| DE69706657D1 (de) | 2001-10-18 |
| US6884411B1 (en) | 2005-04-26 |
| DE69706657T2 (de) | 2002-06-20 |
| JP2000506839A (ja) | 2000-06-06 |
| KR100394382B1 (ko) | 2004-02-05 |
| ES2160927T3 (es) | 2001-11-16 |
| EA199800770A1 (ru) | 1999-02-25 |
| EP0886527B1 (de) | 2001-09-12 |
| KR19990082559A (ko) | 1999-11-25 |
| AU722987B2 (en) | 2000-08-17 |
| PT886527E (pt) | 2001-12-28 |
| EP0886527A1 (de) | 1998-12-30 |
| BR9707772A (pt) | 2000-01-04 |
| AU2229997A (en) | 1997-09-16 |
| WO1997031649A1 (en) | 1997-09-04 |
| GEP20012489B (en) | 2001-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR012614A1 (es) | Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento | |
| DK0911033T4 (da) | Anvendelse af konsensusinterferon til reduktion af bivirkningerne af interferonbehandling i viral hepatitis | |
| DK0871748T3 (da) | Indgivelse af biologisk aktive polypeptider | |
| ATE165000T1 (de) | Dosierungsform zur verzoegerten wirkstofffreisetzung | |
| BRPI0108435B8 (pt) | formulação e uso de entecavir de baixa dose | |
| MX171191B (es) | Composiciones farmaceuticas de glipizida | |
| DK0527835T3 (da) | Doseringsform til afgivelse af et anti-Parkinsonmiddel | |
| IL87621A0 (en) | Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them | |
| AU7589587A (en) | Low dosage of interferon to enhance vaccine efficiency | |
| NZ334270A (en) | Glucagon like peptide (GLP-1), analogs and derivatives to treat post surgical catabolic changes and insulin resistance | |
| AR019551A1 (es) | Uso de la ribavirina en combinacion con el interferon alfa para la fabricacion de un medicamento para la terapia de combinacion para erradicar hcv-rna detectable en pacientes no afectados a tratamiento antiviral que tienen infeccion de hepatitis c cronica | |
| RU92016463A (ru) | Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе | |
| ATE205397T1 (de) | Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen | |
| BR0108997A (pt) | Terapia imune adjuvante para hiv | |
| ATE220332T1 (de) | Behandlung von hepatitis b mit thymosin alpha 1 und lamivudin | |
| AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
| ATE43498T1 (de) | Pyrethroid enthaltende pharmazeutische zubereitungen. | |
| KR950702838A (ko) | 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4) | |
| OA08768A (fr) | Traitement du virus su SIDA par l'interféron alpha humain recombinant. | |
| DK0427633T3 (da) | Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer | |
| Tsybul'skiĭ et al. | The immunomodulating action of mytilan in an experimental influenza infection | |
| FI930097A7 (fi) | Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten | |
| ATE348628T1 (de) | Behandlung von hepatitis c mit thymosin, interferon und ribavirin | |
| IT1283945B1 (it) | Uso dell'interferone alfa naturale umano da cellule linfoblastoidi per la terapia delle epatiti virali, neoplasie e sindromi da | |
| IT1284852B1 (it) | Uso dell'interferone alfa naturale umano da cellule leucocitarie per la terapia delle epatiti virali, neoplasie e sindromi da |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |